Charles River Laboratories International, Inc. released its business outlook, highlighting its portfolio and its plan to focus on four key initiatives in an effort to drive shareholder value. The initiatives include: 1) Improving the consolidated operating margin by managing its cost structure and driving operating efficiencies, with the goal of 20% within three to five years, depending on the demand for preclinical services, 2) Pursuing strategic alternatives for non-strategic or under...